Delta’s stock drops after a profit miss and downbeat outlook on revenue growth Post Content October 10, 2024
Tilray stock gains after earnings report, and upbeat outlook on cannabis legalization Post Content October 10, 2024
Pfizer announces positive data from late-stage trial of prostate cancer combo treatment Post Content October 10, 2024
Biogen’s stock bounces after treatment for kidney-transplant rejection gets FDA boost Post Content October 9, 2024
Scholar Rock’s stock soars more than 200% on positive trial of treatment for spinal muscular atrophy Post Content October 7, 2024
